AxoGen

NASDAQ
AXGN
Stock
Yield per half year: +0.122%
Dividend yield: 0%
Sector: Healthcare

16.41 $

0 $ ( 0%)
9.29 $
20.11 $

Min/max per year

Share chart AxoGen

Main settings

Currency
usd
Dividend income of JSC
6.76
Dividend of JSC
1
IPO Time
1990-03-27
ISIN
US05463X1063
Industry
Health Care Equipment & Supplies
Report Currency
usd
Sector
Health Care
Website

Grade

Underestimation
Title Value Grade
P/S 3.9 4
P/BV 7.02 1
P/E -62.9 0
Efficiency
Title Value Grade
ROA -4.98 0
ROE -9.99 0
ROIC -17.66 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0.8333 8.33
Average dividend growth 28.09 10
Debt
Title Value Grade
Debt/EBITDA 11.3 0
Debt/Ratio 0.3371 10
Debt/Equity 0.9607 9
Growth impulse
Title Value Grade
Revenue, bln, % 66.82 8
Ebitda, % -130.7 0
EPS, % -61.38 0

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 16.41 $ 0 $ 0 $ 0 % 0 % 0 %
Week 16.04 $ 16.41 $ 16.8 $ +2.31 % 0 % 0 %
Month 16.26 $ 14.79 $ 16.8 $ +0.9225 % 0 % 0 %
Three month 12.05 $ 9.73 $ 16.8 $ +36.18 % 0 % 0 %
Half a year 16.39 $ 9.29 $ 18.99 $ +0.122 % 0 % 0 %
Year 16.73 $ 9.29 $ 20.11 $ -1.91 % 0 % 0 %
3 years 10.75 $ 3.54 $ 20.11 $ +52.65 % 0 % 0 %
5 years 19.94 $ 3.54 $ 23.29 $ -17.7 % 0 % 0 %
10 years 5.72 $ 3.54 $ 55.85 $ +186.89 % 0 % 0 %
Year to date 17.42 $ 9.29 $ 20.11 $ -5.8 % 0 % 0 %

Insider trading

Main owners

Similar companies



Company management

Head Job title Payment Year of birth
Ms. Doris Quackenbush Vice President of Sales N/A
Mr. Marc A. Began Executive VP, General Counsel & Chief Compliance Officer N/A 1968 (57 years)
Mr. Jens Schroeder Kemp Chief Marketing Officer N/A
Mr. Erick DeVinney Chief Innovation Officer N/A 1976 (49 years)
Mr. Harold D. Tamayo Vice President of Finance & Investor Relations N/A
Dr. Ivica Ducic M.D., Ph.D. Chief Medical Officer N/A
Mr. Todd Puckett Vice President of Operations
Ms. Karen Zaderej Advisor 1962 (63 years)

About company

Address: United States, Alachua, 13631 Progress Boulevard - Open in google maps, Open in yandex maps
Website: http://www.axogeninc.com

About AxoGen

AxoGen — разработчик хирургических решений, в том числе трансплантатов тканей человека, базируется в Алачуа, Флорида. Продукция Axogen предназначена для лечения повреждений периферических нервов. В 2013 году компания привлекла 18 миллионов долларов в ходе первичного публичного размещения акций.